SPAC Update – February 6

– VCXB terminated Sparks Energy deal
– FRXB terminated HyperloopTT deal
– VHAQ terminated Suneva Medical deal
– ANZU entered letter of intent with Envoy Medical
– LFAC announced trust will not cover excise tax, NAV $10.35
– SWSS filed DEF14a to extend deadline to Aug 28 2023, vote Feb 23, NAV $10.23, trust will not be used to cover any potential excise tax
– JWSM stockholders approved deadline extension to Feb 4 2024, 101.4 million shares (98.0%) redeemed, 2.1 million shares remain
– PMGM postponed vote to Feb 10, trust account will not cover potential excise tax
– OPA filed PRE14a to extend deadline to July 25 2023 + 3 months
– APXI filed DEF14a to amend extension payment, vote Feb 27, NAV $10.38
– MCAE announced 1.5 million shares (94.7%) redeemed, 85k shares remain
– AMCI adjourned deal vote to Feb 6
– HPX filed DEFM14a for Ambipar Response deal, vote Feb 28, NAV $10.06
– PIAI filed PRE14a to extend deadline to Apr 14 2023, vote Mar 3
– FSNB filed DEFR14a to extend deadline to Sept 2 2023, vote Feb 28, NAV $10.16
– IQMD postponed extension vote to Feb 8
– EBAC filed DEFM14a for Oculis SA deal, vote Feb 28
– CFFE filed PRE14a to extend deadline to Sept 16 2023, vote in Mar, NAV $10.62
– MSSA extended deadline to Mar 5 2023, added $187k to trust account
– QFTA extension vote
– MCAA extension vote
– PFDR redemption
– IPAX redemption
– IRRX redemption
– WQGA redemption
– ACAC redemption